You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Express Scripts
Colorcon
McKinsey
Boehringer Ingelheim

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Disopyramide phosphate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for disopyramide phosphate and what is the scope of patent protection?

Disopyramide phosphate is the generic ingredient in three branded drugs marketed by Nesher Pharms, Gd Searle Llc, Aurolife Pharma Llc, Interpharm, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Sun Pharm Industries, Superpharm, Teva, and Watson Labs, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for disopyramide phosphate. Seven suppliers are listed for this compound.

Recent Clinical Trials for disopyramide phosphate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AberdeenN/A
University of OxfordN/A

See all disopyramide phosphate clinical trials

Pharmacology for disopyramide phosphate
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for disopyramide phosphate

US Patents and Regulatory Information for disopyramide phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc NORPACE CR disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 018655-001 Jul 20, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070470-001 Dec 10, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070241-001 Feb 2, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Teva DISOPYRAMIDE PHOSPHATE disopyramide phosphate CAPSULE;ORAL 070102-001 Feb 22, 1985 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Moodys
McKesson
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.